ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesK71.8

K71.8

Billable

Toxic liver disease with other disorders of liver

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K71.8 is a billable code used to indicate a diagnosis of toxic liver disease with other disorders of liver.

Key Diagnostic Point:

Toxic liver disease with other disorders of the liver, coded as K71.8, encompasses a range of hepatic conditions resulting from exposure to various toxins, including drugs, chemicals, and alcohol. Clinically, patients may present with symptoms such as jaundice, abdominal pain, fatigue, and elevated liver enzymes. The liver, a vital organ in the digestive system, plays a crucial role in metabolizing substances, detoxifying harmful compounds, and producing essential proteins. Toxic liver disease can lead to progressive liver damage, potentially resulting in acute liver failure or chronic liver disease if the underlying cause is not addressed. Diagnostic considerations include a thorough patient history, laboratory tests to assess liver function, imaging studies, and sometimes liver biopsy to evaluate the extent of damage. It is essential to differentiate K71.8 from other liver disorders, such as alcoholic liver disease (K70) and viral hepatitis (B15-B19), to ensure appropriate management and treatment.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires comprehensive evaluation of patient history and potential toxin exposure.
  • Treatment complexity: Management may involve cessation of toxin exposure, supportive care, and monitoring for liver function.
  • Documentation requirements: Detailed documentation of symptoms, diagnostic tests, and treatment plans is necessary.
  • Coding specificity: Requires accurate coding to differentiate from other liver conditions.

Audit Risk Factors

  • Common coding errors: Misclassification of liver disorders or failure to document the specific toxin involved.
  • Documentation gaps: Incomplete patient history or lack of supporting lab results.
  • Billing challenges: Potential denials if documentation does not clearly support the diagnosis.

Specialty Focus

Medical Specialties

Hepatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Toxic liver disease significantly impacts population health, as it can lead to severe liver dysfunction and increased healthcare utilization. The prevalence of liver disease related to toxic exposures is a growing concern, particularly with the rise in prescription drug use and environmental toxins. Quality measures focus on early detection and management to prevent progression to chronic liver disease or liver failure, highlighting the importance of awareness and education among healthcare providers.

ICD-9 vs ICD-10

Toxic liver disease significantly impacts population health, as it can lead to severe liver dysfunction and increased healthcare utilization. The prevalence of liver disease related to toxic exposures is a growing concern, particularly with the rise in prescription drug use and environmental toxins. Quality measures focus on early detection and management to prevent progression to chronic liver disease or liver failure, highlighting the importance of awareness and education among healthcare providers.

Reimbursement & Billing Impact

Reimbursement considerations include ensuring that the medical necessity of tests and treatments is clearly documented. Common denials may arise from insufficient documentation linking the diagnosis to the patient's clinical presentation. Best practices include maintaining thorough records of patient history, lab results, and treatment plans to facilitate accurate coding and reduce the risk of audits.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K71.8?

K71.8 covers toxic liver diseases resulting from exposure to various toxins, including medications, industrial chemicals, and other harmful substances. It may also include conditions like drug-induced liver injury and toxic hepatitis, which require specific diagnostic criteria to establish.

When should K71.8 be used instead of related codes?

K71.8 should be used when the liver disease is specifically attributed to toxic exposure, differentiating it from other liver conditions such as K70 for alcoholic liver disease or K73 for chronic hepatitis. Accurate documentation of the toxin and its effects is crucial for appropriate code selection.

What documentation supports K71.8?

Documentation for K71.8 should include a detailed patient history indicating exposure to potential toxins, laboratory results showing liver function tests, imaging studies if performed, and any treatment plans initiated. Clear evidence of the relationship between the toxin and liver dysfunction is essential.